今更ですが、昨年、下記のLinepharmaがEU諸国で承認を受けたという話を知りました。忘備録としてサマリーだけ引用しておきます。
On 21 June 2012, the European Medicines Agency completed an arbitration procedure following a disagreement among Member States of the European Union (EU) regarding the authorisation of the medicine Mifepristone Linepharma. The Agency’s Committee for Medicinal Products for Human Use (CHMP) concluded that the benefits of Mifepristone Linepharma outweigh its risks, and recommended that the marketing authorisation granted in Sweden be recognised in other Member States of the EU.
こちらにEuropean Medicines Agencyの詳細があります。
